Tuesday, November 5, 2024
HomeTagsReCode Therapeutics

ReCode Therapeutics

ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in Three Posters at the ATS 2022 International Conference

ReCode Therapeutics, a biopharmaceutical company powering the next wave of genetic medicines through superior delivery presented new preclinical data from the company’s inhaled mRNA-based...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics